Fig. 4From: The prognosis of recurrent low-grade endometrial stromal sarcoma: a retrospective cohort studyProgression-free intervals (PFI) after first recurrence in patients with and without surgical treatment adjusted with hormone treatment (a), chemotherapy (b) or radiotherapy (c); and overall survival (OS) after the diagnosis of first recurrence in patients with and without surgical treatment adjusted with hormone treatment (c), chemotherapy (d) or radiotherapy (e). 95% CI 95% confidence interval, HR hazard ratioBack to article page